Literature DB >> 20215524

Loss of DNA polymerase zeta enhances spontaneous tumorigenesis.

John P Wittschieben1, Vaishali Patil, Veronika Glushets, Lisa J Robinson, Donna F Kusewitt, Richard D Wood.   

Abstract

Mammalian genomes encode at least 15 distinct DNA polymerases, functioning as specialists in DNA replication, DNA repair, recombination, or bypass of DNA damage. Although the DNA polymerase zeta (polzeta) catalytic subunit REV3L is important in defense against genotoxins, little is known of its biological function. This is because REV3L is essential during embryogenesis, unlike other translesion DNA polymerases. Outstanding questions include whether any adult cells are viable in the absence of polzeta and whether polzeta status influences tumorigenesis. REV3L-deficient cells have properties that could influence the development of neoplasia in opposing ways: markedly reduced damage-induced point mutagenesis and extensive chromosome instability. To answer these questions, Rev3L was conditionally deleted from tissues of adult mice using MMTV-Cre. Loss of REV3L was tolerated in epithelial tissues but not in the hematopoietic lineage. Thymic lymphomas in Tp53(-/-) Rev3L conditional mice occurred with decreased latency and higher incidence. The lymphomas were populated predominantly by Rev3L-null T cells, showing that loss of Rev3L can promote tumorigenesis. Remarkably, the tumors were frequently oligoclonal, consistent with accelerated genetic changes in the absence of Rev3L. Mammary tumors could also arise from Rev3L-deleted cells in both Tp53(+/+) and Tp53(+/-) backgrounds. Mammary tumors in Tp53(+/-) mice deleting Rev3L formed months earlier than mammary tumors in Tp53(+/-) control mice. Prominent preneoplastic changes in glandular tissue adjacent to these tumors occurred only in mice deleting Rev3L and were associated with increased tumor multiplicity. Polzeta is the only specialized DNA polymerase yet identified that inhibits spontaneous tumor development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215524      PMCID: PMC3008348          DOI: 10.1158/0008-5472.CAN-09-4267

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

Review 2.  The role of p53 in tumour suppression: lessons from mouse models.

Authors:  L D Attardi; T Jacks
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

3.  Effects of genetic background on tumorigenesis in p53-deficient mice.

Authors:  L A Donehower; M Harvey; H Vogel; M J McArthur; C A Montgomery; S H Park; T Thompson; R J Ford; A Bradley
Journal:  Mol Carcinog       Date:  1995-09       Impact factor: 4.784

4.  Immortalized mouse cell lines that lack a functional Rev3 gene are hypersensitive to UV irradiation and cisplatin treatment.

Authors:  Linda Zander; Mats Bemark
Journal:  DNA Repair (Amst)       Date:  2004-07-02

5.  A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta.

Authors:  P E Gibbs; W G McGregor; V M Maher; P Nisson; C W Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

6.  Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.

Authors:  J M Ward; L Tadesse-Heath; S N Perkins; S K Chattopadhyay; S D Hursting; H C Morse
Journal:  Lab Invest       Date:  1999-01       Impact factor: 5.662

7.  High-frequency developmental abnormalities in p53-deficient mice.

Authors:  J F Armstrong; M H Kaufman; D J Harrison; A R Clarke
Journal:  Curr Biol       Date:  1995-08-01       Impact factor: 10.834

8.  Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals.

Authors:  Sigal Shachar; Omer Ziv; Sharon Avkin; Sheera Adar; John Wittschieben; Thomas Reissner; Stephen Chaney; Errol C Friedberg; Zhigang Wang; Thomas Carell; Nicholas Geacintov; Zvi Livneh
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

9.  T cell receptor (TCR)-beta gene recombination: dissociation from cell cycle regulation and developmental progression during T cell ontogeny.

Authors:  M R Tourigny; S Mazel; D B Burtrum; H T Petrie
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

10.  Pol zeta ablation in B cells impairs the germinal center reaction, class switch recombination, DNA break repair, and genome stability.

Authors:  Dominik Schenten; Sven Kracker; Gloria Esposito; Sonia Franco; Ulf Klein; Michael Murphy; Frederick W Alt; Klaus Rajewsky
Journal:  J Exp Med       Date:  2009-02-09       Impact factor: 14.307

View more
  40 in total

Review 1.  Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.

Authors:  Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2019-03-07

2.  REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1.

Authors:  Abel Chiu-Shun Chun; Kin-Hang Kok; Dong-Yan Jin
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  DNA polymerase ζ is a major determinant of resistance to platinum-based chemotherapeutic agents.

Authors:  Shilpy Sharma; Nicholas A Shah; Ariell M Joiner; Katelyn H Roberts; Christine E Canman
Journal:  Mol Pharmacol       Date:  2012-03-02       Impact factor: 4.436

4.  Participation of translesion synthesis DNA polymerases in the maintenance of chromosome integrity in yeast Saccharomyces cerevisiae.

Authors:  O V Kochenova; J V Soshkina; E I Stepchenkova; S G Inge-Vechtomov; P V Shcherbakova
Journal:  Biochemistry (Mosc)       Date:  2011-01       Impact factor: 2.487

5.  Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress.

Authors:  Ilya N Kotov; Ellen Siebring-van Olst; Philip A Knobel; Ida H van der Meulen-Muileman; Emanuela Felley-Bosco; Victor W van Beusechem; Egbert F Smit; Rolf A Stahel; Thomas M Marti
Journal:  Mol Oncol       Date:  2014-07-22       Impact factor: 6.603

6.  Breakthrough for a DNA break-preventer.

Authors:  Richard D Wood; Sabine S Lange
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-14       Impact factor: 11.205

7.  Six Germline Genetic Variations Impair the Translesion Synthesis Activity of Human DNA Polymerase κ.

Authors:  Jae-Kwon Kim; Mina Yeom; Jin-Kyung Hong; Insil Song; Young-Sam Lee; F Peter Guengerich; Jeong-Yun Choi
Journal:  Chem Res Toxicol       Date:  2016-09-21       Impact factor: 3.739

8.  A missense mutation in Rev7 disrupts formation of Polζ, impairing mouse development and repair of genotoxic agent-induced DNA lesions.

Authors:  Maryam Khalaj; Abdolrahim Abbasi; Hiroshi Yamanishi; Kouyou Akiyama; Shuso Wakitani; Sotaro Kikuchi; Michiko Hirose; Misako Yuzuriha; Masaki Magari; Heba A Degheidy; Kuniya Abe; Atsuo Ogura; Hiroshi Hashimoto; Tetsuo Kunieda
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

9.  Dual role for mammalian DNA polymerase ζ in maintaining genome stability and proliferative responses.

Authors:  Sabine S Lange; Ella Bedford; Shelley Reh; John P Wittschieben; Steve Carbajal; Donna F Kusewitt; John DiGiovanni; Richard D Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

Review 10.  REV1 and DNA polymerase zeta in DNA interstrand crosslink repair.

Authors:  Shilpy Sharma; Christine E Canman
Journal:  Environ Mol Mutagen       Date:  2012-10-13       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.